Literature DB >> 1922146

Use of the clonal assay for the measurement of frequencies of HPRT mutants in T-lymphocytes from five control populations.

A D Tates1, F J van Dam, H van Mossel, H Schoemaker, J C Thijssen, V M Woldring, A H Zwinderman, A T Natarajan.   

Abstract

The clonal assay was used to measure frequencies of 6-thioguanine-resistant (HPRT) T-lymphocytes in 111 donors from the following 5 control populations: 55 adult healthy volunteers; 20 untreated cancer patients; 8 healthy hospital workers serving as controls for 9 hospital workers sterilizing equipment with ethylene oxide; 15 factory workers serving as controls for 15 workers occupationally exposed to high doses of ethylene oxide; 13 pretreatment samples from donors undergoing a diagnostic test with Technetium-99m for an analysis of heart function. With respect to mutant frequency (MF), cloning efficiency (CE) and age distribution, the first 4 populations were identical. The Technetium group had significantly higher MFs and lower CEs but this can be attributed to the higher mean age of this group. Using the total data base, we calculated the following relationships between MF, CE, age and smoking: (1) ln MF = 4.23-0.63 x ln CE indicating that a doubling of the CE has the effect of decreasing the MF by 37%, (2) ln MF = 0.71 + 0.03 x age meaning that the MF increases by 3% from one year to the next, (3) ln CE = 4.87-0.04 X age indicating that the CE decreases by 0.98% from one year to the next, (4) ln MF = 3.25-0.52 x ln CE + 0.02 X age being the equation quantifying the interrelationship between MF, CE and age, (5) ln MF = 3.32-0.56 x ln CE + 0.01 x age + 0.31 s (where s = 1 for smokers and s = 0 for nonsmokers). Using the latter equation, which allows for effects of CE and age on the MF, a statistically significant effect of smoking could be established. For any combination of CE and age smoking has the effect of increasing the MF by 36%. The above conclusions and calculations remain essentially the same when donors with cloning efficiencies lower than 10 or 20% are excluded from the data base.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1922146     DOI: 10.1016/0165-1161(91)90133-s

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  7 in total

1.  Influence of sex, smoking and age on human hprt mutation frequencies and spectra.

Authors:  J Curry; L Karnaoukhova; G C Guenette; B W Glickman
Journal:  Genetics       Date:  1999-07       Impact factor: 4.562

Review 2.  Somatic mutations in aging, cancer and neurodegeneration.

Authors:  Scott R Kennedy; Lawrence A Loeb; Alan J Herr
Journal:  Mech Ageing Dev       Date:  2011-11-03       Impact factor: 5.432

3.  Effect of hormones on the variation of radiosensitivity in females as measured by induction of chromosomal aberrations.

Authors:  C J Roberts; G R Morgan; N Danford
Journal:  Environ Health Perspect       Date:  1997-12       Impact factor: 9.031

4.  Elevated levels of somatic mutation in a manifesting BRCA1 mutation carrier.

Authors:  Stephen G Grant; Rubina Das; Christina M Cerceo; Wendy S Rubinstein; Jean J Latimer
Journal:  Pathol Oncol Res       Date:  2007-12-25       Impact factor: 3.201

5.  Mutations induced in the hypoxanthine phosphoribosyl transferase gene by three urban air pollutants: acetaldehyde, benzo[a]pyrene diolepoxide, and ethylene oxide.

Authors:  B Lambert; B Andersson; T Bastlova; S M Hou; D Hellgren; A Kolman
Journal:  Environ Health Perspect       Date:  1994-10       Impact factor: 9.031

6.  Mechanisms for induction of mutations and chromosome alterations.

Authors:  A T Natarajan
Journal:  Environ Health Perspect       Date:  1993-10       Impact factor: 9.031

7.  Analysis of gene expression using gene sets discriminates cancer patients with and without late radiation toxicity.

Authors:  J Peter Svensson; Lukas J A Stalpers; Rebecca E E Esveldt-van Lange; Nicolaas A P Franken; Jaap Haveman; Binie Klein; Ingela Turesson; Harry Vrieling; Micheline Giphart-Gassler
Journal:  PLoS Med       Date:  2006-10       Impact factor: 11.069

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.